The Whooping Cough Vaccine (DTaP) doesn’t work, since 1996. No Herd Immunity.

Doesn’t prevent the infection of whooping cough (pertussis).

Doesn’t give anyone immunity.

No herd immunity, since at least 1996.

I know you’re glaring at me, saying “SHOW ME THE SCIENCE.”  Relax those veins in your neck, and read it for yourself:

Scientists from Boston University, 2018:

https://www.bu.edu/sph/2017/09/21/resurgence-of-whooping-cough-may-owe-to-vaccines-inability-to-prevent-infections/

Background

DTP (whole cell) vaccine version, was introduced in the late 1940s, but was causing so many deaths and injuries and disablement, that it was replaced with the DTAP (the acellular version), which was put into use in 1996 in the United States (DTP was still available in some doctor’s offices, and given in the U.S. until about 1999).

In a meta-analysis of the three studies of the introduction of DTP in children ages 0 – 3, in urban and rural Guinea-Bissau (Africa) from 1980 – 1983, DTP-vaccinated children had twofold higher mortality than DTP-unvaccinated children.

Find more information about these Guinea-Bissau studies by reading this post.

Now, back to the DTaP….

What does this mean?  This means that the DTAP aceulluar only got rid of your SYMTPOMS, not the disease, as the DTP whole cell vaccine (supposedly) did – MEANING, that the DTP doesn’t prevent the SPREADING of the disease!!!!  It only knocks out some of the symptoms!

That’s right, we have had NO herd immunity in the child population since 1996!   Can you believe that we weren’t dying in the streets all this time?  :::sarcasm:::

Not only is this stupid, but it’s dangerous.  If grandma GETS the DTAP vaccine, and is then exposed to the whooping cough infection, she will still catch the infection, and due to her suppression of symptoms, won’t realize she has the infection, and she will come over and hold your newborn and she will carry whooping cough right into your baby’s arms.  Grandma doesn’t know she’s a carrier of the disease, because her symptoms have been ‘taken away’ by the DTAP vaccine.  If Grandma hadn’t gotten the vaccine, and was exposed to and contracted the whooping couch infection, she would KNOW she has the whooping cough.  How?  From her COUGH (symptoms)!  Symptoms are an important signal, telling us when we are infectious and contagious.

Now, if your grandma had whooping cough earlier in life — not the vaccine — but the actual infection, she can come over anytime, because having the real infection has give her LIFELONG IMMUNITY!  She doesn’t need any vaccine!  The whooping cough bacteria will never colonize her body again insofar as it will make her contagious (a carrier).

WOW.  Doesn’t sound like settled science to me….does it sound like settled science to you?

Assumptions upon assumptions.  I hate to bash religion, but this vaccine program is a ‘faith-based movement’ – are you starting to see this?  They wanted it to work…they really did….but their desire for science to be the victor over disease is blinding them.  They have faith that science will be the victor, but they actually have no idea what they’re doing.  Their faith is making them biased…so that they can see success in the products and vaccines they’re developing, though the success isn’t there.  I wish vaccines were magic. I wish they worked.  But if we’re going to make decisions based on science, we need to reign in our desire/faith/bias.

We’ve all been a part of a really long experiment – a faith-based one.  A cultish one, based on arrogance and bravado.

Arrogance?  Yes.  Despite this science coming out of Boston University, they still REPEAT: “the science is settled.  Vaccines are effective and safe.”  But we see, they didn’t understand how whooping cough worked, and still don’t appear to understand.  Nor did they understand how the vaccine worked, nor do they now.  This vaccine, along with others, are NOT giving immunity, much less life long immunity.  That is why there are so many outbreaks occurring.  These outbreaks are occurring where?  IN FULLY VACCINATED PEOPLE.

And the final blow…

Yet, our officials, such as Mr. Pan in California, continue to repeat that it is working.  They continue to uphold the law they passed last year, MANDATING the vaccines (including this one).

Are you laughing yet?  Or crying?

http://www.pnas.org/content/111/2/787

What about before 1996?  From the late 1940s to 1996, the DPT vaccine was used.  It was replaced by the DTaP vaccine in 1996 due to so many vaccine injuries and deaths caused by the DPT.   (DPT was still available in some doctor’s offices, and given in the U.S. until about 1999).

‘They’ told us that the DPT vaccine was responsible for eradicating whooping cough up tp 90% efficacy (we will question that below), but it was causing neurological disorders — and though they say it was rare, it wasn’t.  There were so many lawsuits being brought against the pharmaceutical manufacturers regarding the DPT specifically, that pharma to come whining to Congress and Ronald Reagan, saying that unless Congress gave the pharma companies complete immunity from lawsuits, they would stop making vaccines. Congress, along with the public was brainwashed at that point to believe that vaccines had saved people from dying in the streets, so they gave in.  In reality, disease mortality rates declined before vaccines were introduced.

To read more about the injuries and deaths caused by the DPT and other pertussis vaccines, read the summary below, underneath the “Other Vaccines Licensed” list.  To see the most up to date information, visit the National Vaccine Information Center website, from which this information was taken.

Other Pertussis Vaccines Licensed for Use in the U.S.

The U.S. Food and Drug Administration and U.S.Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control (CDC) have approved nine different combination shots that include acelullar pertussis vaccine. There are different rules for use of these vaccines by different ages groups.

Following is a list of currently available vaccine combination shots that contain pertussis vaccine with links to the manufacturer product inserts (click on the name of the product):

• Infanrix, a 3 in 1 combination shot containing diphtheria, tetanus toxoids, and acellular pertussis vaccine for children under 7 years of age. It is manufactured by GlaxoSmithKline.
• Daptacel, a 3 in 1 combination shot containing diphtheria and tetanus toxoids and acellular pertussis vaccine for children under 7 years of age. It is manufactured by Sanofi Pasteur Ltd.
• Pediatrix, a 5 in 1 combination shot containing diphtheria and tetanus toxoids and accelluar pertussis, hepatitis B recombinant and inactivated poliovirus vaccines for children under 7 years of age. It is manufactured by GlaxoSmithKline.
• Kinrix, a 4 in 1 combination vaccine containing diphtheria and tetanus toxoids, acellular pertussis and inactivated poliovirus vaccines for children 4 to 6 years old. It is manufactured by GlaxoSmithKline.
• Pentacel, a 5 in 1 combination shot containing diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus and Haemophilus b conjugate (tetanus toxoid conjugate) vaccines for children under four years old. It is manufactured by Sanofi Pasteur Ltd.
• Adacel, a 3 in 1 combination booster shot containing tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine for those 11 years or older. It is manufactured by Sanofi Pasteur Ltd.
• Boostrix, a 3 in 1 combination booster shot containing tetanus toxoid, reduced dipththeria toxoid and acellular pertussis vaccine for those 10 years or older. It is manufactured by GlaxoSmithKline.
• ActHIB, a Haemophilus influenza b vaccine that can be reconstituted in the doctor’s office to become a 4 in 1 combination shot for children 15 -18 months that contains Tripedia (diphtheria and tetanus toxoids and acellular pertussis vaccine) and Haemophilus Influenza b vaccine. It is manufactured by Sanofi Pasteur.

What’s in the vaccine?   You can find these answers from a number of sources.  

• Vaccine Package Insert – they don’t even often list the ingredients in the table of contents, so after you navigate to an insert, use the control+f on your computer to search for “ingredient.”  There are so many flu vaccines that I can’t copy and paste all the ingredient lists here.  The Vaccine Package Insert for vaccines are filed on the CDC website, but it can be extremely difficult to find.  The National Vaccine Information Center makes the process of locating the insert much easier: https://www.nvic.org/vaccines-and-diseases/influenza/vaccine.aspx
• http://www.vaxcalc.org is updating their vaccine ingredient tool every day.  They don’t have every vaccine listed yet, but they are working on it.

What injury does it cause?  You can find these answers from a number of sources.  

• Vaccine Package Insert – they use the term “Post-Marketing Experience” to describe documented injuries.  Again, there are so many flu vaccines that I can’t copy and paste all injury lists from all of the inserts here.  Use the link below to find navigate the CDC list of flu vaccines.  Select one, and use the control+f on your computer to search for that term, or look in the table of contents of the Vaccine Package. Insert.  The Vaccine Package Insert for vaccines are filed on the CDC website, but it can be extremely difficult to find.  The National Vaccine Information Center makes the process of locating the insert much easier: https://www.nvic.org/vaccines-and-diseases/influenza/vaccine.aspx
• Real stories from thousands of parents and children around the world – YouTube playlist – 
  • DPT/DTP: https://www.youtube.com/watch?v=_WTUFvAHZHM&list=PL_H9IShCZAbhy8K7nHhUGKAhJa-sp76Qv
  • DTaP/TDap: https://www.youtube.com/watch?v=fq2NYM4MbR4&list=PL_H9IShCZAbiHO6HWA2-6iacukwrY5qIb

• Summary of the injuries and deaths caused by the DPT vaccine, from the National Vaccine Information Center.

  Please note, injuries and deaths have also occurred from the DTaP version, as well as the Tdap version.   To read the entire article from the National Vaccine Information Center, please visit this link.

• VAERS Data – for 2018 thru June
  • Death: 3 people
  • ER visits: 7 people
  • Hospitalized: 7 people (1 for 10 days)
  • Permanently disabled: 6 people
  • Other injuries: TONS!!!!!!!!!
• Vaccine Injury Compensation Fund.  I can’t figure out how to find out what injuries or deaths have been awarded, much less what vaccine it was associated with.  All I can find is the list of injuries for which the fund compensates for the flu and influenza vaccines.  *Note, this is a minuscule list of injuries compared with the list of injuries that are reported on VAERS.*

How to Prevent or Treat Whooping Cough?

Suzanne also points out that antibiotics make the cough worse as it impairs the immune system.  Suzanne has treated whooping cough successfully in those of all ages – from infants as young as 2 weeks of age, to the elderly, with no secondary infections occurring., and she has never lost a baby.

• Sodium ascorbate (vitamin C) high-dose treatment: https://drive.google.com/file/d/1ODk9tmlUtRDfra1713Ugm84JrXYYgVv2/view
• Success Stories to boost your condense: http://drsuzanne.net/suzanne-humphries-md-testimonials/

More from the NVIC…

How Effective Is Pertussis Vaccine?

Most public health officials maintain that when pertussis vaccine is used on a widespread basis in a population, it appears to lessen the overall incidence of the disease and that vaccinated children have less severe cases of pertussis whooping cough. When pertussis vaccination rates fell to about 30 percent in Sweden, West Germany, England, and Japan in the 1970’s, these countries saw major increases in reported cases of the disease within three years of that drop in widespread use.

However, in 1984, Swedish epidemiologist B. Trollfors concluded that whole cell B. pertussis vaccines are only effective for 2 to 5 years. He pointed out that even countries with a 90-95 percent vaccination rate (such as the U.S.) could not completely prevent the disease.

In 2010, an analysis of a California whooping cough outbreak published in the medical literature revealed that more than 80% were fully vaccinated and pertussis vaccine effectiveness was only between 24% and 41% in children two to 18 years old after three years from the date of vaccination.

In 2012, the CDC acknowledged that pertussis vaccine immunity has waned in older children, that DTaP/Tdap immunity begins to wane within five years of vaccination and that unvaccinated individuals and children with vaccine exemptions are not to blame for current whooping cough outbreaks.

There is another Bordetella pertussis whooping cough disease called B. parapertussis. Symptoms of B. parapertussis whooping cough can look identical to B, pertussis whooping cough but they are usually milder. B, parapertussis is increasing in the U.S. and other countries, which have had high pertussis vaccination rates for few decades. There are estimates that perhaps up to 30 percent of whooping cough disease in highly vaccinated populations may be  caused by B. parapertussis organisms.

It is possible to have both B. pertussis and B. parapertussis infections at the same time. Parapertussis is often milder than B. pertussis but can also involve serious complications which lead to pneumonia and death.

Pertussis vaccines widely used around the world do not protect against parapertussis. There is no vaccine for parapertussis.

There is also some evidence that B. pertussis bacteria may have evolved to become vaccine resistant.

Other evidence points to emerging pertussis strains that are not covered in the current DTaP/Tdap and DTP pertussis containing vaccines used in the U.S. and globally.

Can Pertussis Vaccine Cause Injury or Death?

Vaccines are pharmaceutical products and, like all pharmaceutical products, carry a risk of injury or death that can be greater for some than others. The risk for injury or death from vaccination depends upon the vaccine or vaccines given; the individual’s health at time of vaccination; vaccine reaction history; personal or family medical history and whether the child or adult are exposed to other environmental toxins or factors that may affect immune responses to vaccination.

B. pertussis bacteria, which cause pertussis whooping cough disease, and lab altered to make pertussis vaccine, contain several toxins that can cause inflammation in the body. Pertussis toxin (PT) is one of the most lethal toxins in nature. The toxin induces lymphocytosis, leukocytosis, stimulates insulin secretion and sensitizes histamine, which is involved in the immune system’s inflammatory response.

Pertussis toxin is thought to be the main component of B pertussis bacteria responsible for stimulating the production of protective antibodies during natural whooping cough infection and after pertussis vaccination. But pertussis toxin is also thought to be the main component responsible for causing brain inflammation during B. pertussis whooping cough or after injection of pertussis-containing vaccines.

Since the 1950’s, scientists have injected pertussis toxin into lab animals whenever they want to deliberately induce histamine, serontonin and endotoxin sensitivity or experimental autoimmune encephalomyelitis.  Because pertussis toxin can cross the blood brain barrier when conditions are right, brain inflammation (encephalitis) that causes permanent brain damage has always been the most dreaded serious complication of both whooping cough and pertussis vaccination.

The acellular pertussis vaccine (DTaP/Tdap) vaccines still contain chemically inactivated pertussis toxin (10-25 mcg per dose) that retain varying amounts of bioactivity, which may induce brain inflammation in some individuals. A company producing a genetically engineered DTaP vaccine in the early 1990’s, Chiron, explained one reason why chemically inactivated pertussis toxin will be a problem for some: “Genetic detoxification ensures than no active form of the pertussis toxin is present, while chemically detoxified pertussis toxins may revert to toxicity.”

Another toxin produced by B. pertussis bacteria during natural infection is endotoxin, which is also present in pertussis vaccines in varying amounts. When the immune system detects the presence of endotoxins, it produces a defensive inflammatory immune response, including the release of large amounts of histamine that can, under certain circumstances, lead to high fever, swelling, diarrhea, collapse, shock and death.

The authors of the 1981 British National Childhood Encephalopathy Study (NCES) noted in 1993, and the Institute of Medicine confirmed in 1994, that brain inflammation and encephalopathy is associated with a broad range of long term brain dysfunction that affects the physical, social, behavioral and educational outcomes for children. Signs of brain inflammation in infants or very young children can include high fever; irritability; vomiting; high pitched screaming (encephalitic cry) with or without arching of back; prolonged, uncontrollable crying; collapse and unresponsiveness with pale skin and blue lips; crossing or wandering eyes; drowsiness/lethargy; convulsions (seizures) with or without fever; regression and loss of developmental milestones and negative changes in mental, emotional and physical health. Death or a diagnosis of mental retardation, medication resistant seizure disorders, learning disabilities, attention deficit disorder, autism and other chronic neurological and health problems may follow an acute brain inflammation.

In 1991, the Institute of Medicine (IOM), National Academy of Sciences, published the first of four reports of expert committees, which reviewed the medical literature for evidence that vaccines can cause injury and death. The literature review was mandated under the National Childhood Vaccine Injury Act of 1986. The 1991 IOM report on Adverse Effects of Pertussis and Rubella Vaccines concluded that “evidence is consistent with a causal relation between DPT vaccine and acute encephalopathy (brain inflammation) and “unusual shock-like state” (hypotonic/hyporesponsive episode): and that “evidence indicates a causal relation between DPT vaccine and shock (anaphylaxis) and protracted, inconsolable crying.”

In 1994, the IOM published the report DPT Vaccine and Chronic Nervous System Dysfunction after reviewing the 10-year follow up the British NCES study and concluded that “NCES data are consistent with the possibility that some children without underlying brain or metabolic abnormalities might experience serious acute neurologic illness within 7 days after receiving DPT and that acute illness could have chronic nervous system sequelae. The NCES data also are consistent with the possibility that some children with underlying brain or metabolic abnormalities (which foster a “triggering” by DPT of an acute neurologic illness) might go on to develop chronic nervous system dysfunction due to a DPT-triggered acute illness. Therefore the committee concludes that the balance of evidence is consistent with a causal relation between DPT and the forms of chronic nervous system dysfunction described in NCES in those children who experience a serious acute neurologic illness within 7 days after receiving DPT vaccine.. This serious neurologic risk is a rare event. The estimated excess risk ranged from 0 to 10.5 per million immunizations.”

As of August 2012,  about half of the 2,982 awards for vaccine injury and death totaling nearly $2.5 billion dollars made under the U.S. 1986 National Childhood Vaccine Injury Act involve pertussis containing vaccines.

As of September 1, 2015, there had been 7 claims filed in the federal Vaccine Injury Compensation Program (VICP) for injuries and deaths following pertussis vaccination, including 3 deaths and 4 serious injuries.

Using the MedAlerts search engine, as of December 30, 2015 there had been 19,357 serious adverse events reported to the Vaccine Adverse Events Reporting System (VAERS) in connection with pertussis-containing vaccines since 1990. Over three-fourths of those serious pertussis vaccine-related adverse events occurring in children three years old and under. Of these pertussis-vaccine related adverse event reports to VAERS, 2,512were deaths, with over 90% of the deaths occurring in children under three years of age.

Most pediatric neurologists acknowledge that vaccination, including use of vaccines for smallpox, rabies, influenza, mumps, measles, tetanus, polio and pertussis, can and does occasionally cause neurological complications that can lead to permanent brain dysfunction.

What Does the CDC Advise About Precautions?

The vaccine manufacturer product information inserts contain the most complete information about contraindications and precautions for use of pertussis vaccine. However, federal health officials at the CDC also publish information about what they consider to be contraindications and precautions for use of pertussis containing vaccines, including DTaP and Tdap.

The CDC lists the following CONTRAINDICATIONS to getting pertussis containing (DTP, DTaP, Tdap) vaccines:

• Those who have had a life-threatening allergic reaction after a previous dose of DPT, DTaP or TdaP should not get another dose.
• Those who have suffered a brain or nervous system disease (brain inflammation, coma, convulsions, encephalopathy) within 7 days after a dose of DPT or DTaP should not another dose of pertussis containing vaccine.
• The CDC lists the following PRECAUTIONS to getting a pertussis containing vaccine (DTP, DtaP/Tdap):
• Progressive neurologic disorder, including infantile spasms, uncontrolled epilepsy, progressive encephalopathy; defer DTaP until neurologic status clarified and stablized.
• Temperature of ≥105° F (≥40.5° C or higher) within 48 hours after vaccination with a previous dose of DTP or DTaP
• Collapse or shock-like state (i.e., hypotonic hyporesponsive episode) within 48 hours after receiving a previous dose of DTP/DTaP
• Seizure ≤3 days after receiving a previous dose of DTP/DTaP
• Persistent, inconsolable crying lasting ≥3 hours within 48 hours after receiving a previous dose of DTP/DTaP
• GBS <6 weeks after a previous dose of tetanus toxoid-containing vaccine
• History of arthus-type hypersensitivity reactions after a previous dose of tetanus or diphtheria-toxoid containing vaccines (including MCV4); defer vaccination until at least 10 years have elapsed since the last tetanus toxoid-containing vaccine
• Moderate or severe acute illness with or without fever

Children, who  should not get another dose of pertussis vaccine, often are able to  get a vaccine without pertussis, called DT (diphtheria-tetanus).

Are There Other High Risk Factors for Pertussis Vaccine?

For the first 40 years of use of whole cell pertussis (DPT) vaccine, ABSOLUTE CONTRAINDICATIONS to pertussis vaccination included:

• Temperature of 103 F. or higher within 48 hours after getting a DPT shot;
• Seizure within 3 days after getting a DPT shot;
• Collapse or shock-like state (hypotonic hyporesponsive episode) with 48 hours of getting a DPT shot;
• High pitched screaming or inconsolable crying within 48 hours of getting a DPT shot;
• Acute illness with fever

After the 1986 National Childhood Vaccine Injury Act was passed by Congress creating a federal vaccine injury compensation program and shielding vaccine manufacturers and doctors giving vaccines from civil vaccine injury lawsuits, by  1991, these absolute CONTRAINDICATIONS to receipt of pertussis containing vaccines were re-categorized as “PRECAUTIONS” and parents were told to speak with their doctor about further vaccinations.

In general, the same high risk factors and contraindications for whole cell pertussis vaccine (DPT) are also considered high risk factors and contraindications for DTaP, Tdap or other combination shots containing acellular pertussis vaccine. There may be other circumstances, which could place a child or adult at higher risk for reacting to pertussis vaccine that are not officially recognized by the CDC’s Advisory Committee on Immunization Practices (ACIP), the vaccine manufacturers or the American Academy of Pediatrics. You may want to do your own research and access medical studies on the internet or visit a medical library at a community hospital or university to gain access to the medical literature.

Since 1982, the co-founders of NVIC have been concerned about the lack of scientific studies investigating the biological mechanisms and high risk factors for pertussis vaccine, which has long been associated with reports of injury and death in more than 60 years of medical literature. Acknowledgement of biodiversity and genetic variation between individuals argues for a national scientific research agenda, which responsibly examines the biological factors that predispose some individuals to responding adversely to vaccination, including pertussis vaccination, and suffering brain and immune system damage or death.

In 1946, Werne and Garrow reported the deaths of identical twins within 24 hours of their second diphtheria-pertussis shot. The same outcome in identical twins following receipt of a pertussis vaccine-containing vaccine suggested genetic predisposition. The possibility of genetic predisposition to adverse responses to vaccination has been cited in the scientific literature. Additionally, there have been reports of two, three and four children in the same family, who have experienced serious reactions to pertussis-containing vaccines and suffered permanent brain damage.

Following is a list of potential high risk factors for pertussis vaccine reactions, which are not acknowledged by public health officials, vaccine manufacturers or medical organizations, but which deserve serious scientific investigation.

Family History of Convulsions or Neurological Disease – For most of the time that pertussis vaccine has been used, a personal history of convulsions or neurological disease has been listed as an absolute contraindication or serious precaution. In the past, some European countries have exercised caution and contraindicated pertussis vaccination if a member of the child’s immediate family (brother, sister, mother or father) has a history of convulsions or neurological disease.

The product information circular accompanying DPT vaccine manufactured by Lederle Laboratories in 1985 stated, “Routine immunization with this product should not be attempted if the child has a personal or family history of central nervous system disease or convulsions.”

The product information circular accompanying DPT vaccine manufactured by Connaught Laboratories in 1989 stated, “Use of this product is also contraindicated if the child has a personal or family history of a seizure disorder.”

In 1975, a World Health Organization-sponsored international meeting of pertussis vaccine experts recommended that “children from families with a history of neurological disorders should not be vaccinated.”

In 1977, the Department of Health and Social Security in England stated that children should not be given pertussis vaccine if they have a “family history of epilepsy or other diseases of the central nervous system.”

In a 1987 recommendation published in the Morbidity and Mortality Weekly Report, the CDC stated “recent studies suggest that infants and children with a history of convulsions in the first degree family members (i.e. siblings and parents have a 3.2 fold increase risk for neurologic events compared with those without such histories (CDC, unpublished data).” The CDC went on to recommend, however, that these children should still receive pertussis vaccine.

Premature Birth or Low Birth Weight – Babies who are born prematurely may have neurological, respiratory, and immunological systems that are not as fully developed as those who are full-term. Premature and low weight babies are at high risk for dying from pertussis whooping cough disease but may also be at higher risk for adverse responses to pertussis vaccination.

A 1994 study of 2-month old babies in a special care nursery for premature/low birth weight babies in Dallas showed 19 percent had either new or increased episodes of apnea (stopped breathing) in the 24 to 48 hours after being vaccinated with DPT and HIB vaccines, and some required oxygen and other support to begin breathing again.

Several pertussis containing vaccines on the market today, list apnea as a reported adverse event and also advise caution when vaccinating premature babies with some pertussis containing vaccines.

Cerebral Irritation in the Neonatal Period – Newborn babies can exhibit cerebral irritation following birth, including high pitched screaming (encephalitic cry) with arching of the back, depressed consciousness and other neurological signs. A difficult labor and birth can cause cerebral irritation as can inflammation of the brain from meningitis or other infection. An infant with symptoms of cerebral irritation after birth may be manifesting evidence of a weakened or damaged neurological system that may be especially vulnerable to the inflammatory effects of the pertussis vaccine.

In years past, the British department of Health and Social Security stated that pertussis vaccination “should not be carried out in children who have … a history of cerebral irritation or damage in the neonatal period.”

A Personal or Family History of Severe Allergies and Autoimmune Disorders – A healthy, mature immune system requires an equal balance of cellular (Th1 – innate) and humoral (Th2 – learned) immune system responses to prevent inflammatory responses from remaining unresolved and causing chronic illness. A disruption in immune function can lead to chronic inflammation and development of allergy or autoimmune disorders.

Vaccination does not exactly mimic the natural infection process and often by-passes cellular immunity in favor of humoral immunity (measured by antibodies in the blood). There have been persistent reports that some individuals may be at risk for developing autoimmune disorders after vaccination.

In than 60 years of scientific literature reporting complications of pertussis vaccine, there have been reports by some researchers that a history of severe allergies or autoimmune disorders in a child or his family (eczema, asthma, hay fever, milk allergy) may predispose a child to reacting to the pertussis vaccine. In England in past decades, a personal or family history of allergies was considered a contraindication.

Dow Chemical Company’s DPT product insert in the 1960s stated “fractional doses are recommended in infants with cerebral injury, asthma, a strong family history of allergy …”

In 1961, Hopper found that in a group of babies who reacted strongly to the pertussis vaccine, there was twice as much eczema, asthma, hay fever, and allergic skin rashes in the child, his brothers and sisters, parents, and grandparents as there was in a control group of the same size.

In 1969, Hannik found a positive family history of allergies in a significant proportion of infants who reacted with high-pitched screaming, shock and convulsions.

In 2000, a study comparing the health of vaccinated and unvaccinated children between 1988 and 1994 found that a child who received DPT or tetanus vaccination was 50 percent more likely to experience severe allergic reactions, more than 80 percent more likely to experience sinusitis, and twice as likely to experience asthma as those who were not vaccinated. The conclusion of the authors was that “asthma and other allergic hypersensitivity reactions and related symptoms may be causes, in part, by the delayed effects of DTP or tetanus vaccination.”

A healthy, mature immune system requires an equal balance of cellular (inate) and humoral (learned) immune system responses so that inflammatory responses do not remain unresolved and cause chronic illness. A disruption in immune function can lead to development of allergy and autoimmune disorders. Vaccination does not exactly mimic the natural infection process and often by-passes cellular immunity in favor of humoral immunity. There have been persistent reports of development of autoimmune disorders and allergy after vaccination, including pertussis vaccination.

Milk Allergy (Casein Intolerance) – 1982 and 1985, studies identified genetic susceptibility to pertussis vaccine induces encephalopathy involving genes of the major histocompatibility complex correlating to genetic regulation of antibody responses to bovine serum albumin (a cow’s milk protein).

A personal or family history of allergies, particularly milk (casein) allergy, may be one high risk factor for reacting to pertussis vaccine. There were many cases of pertussis vaccine injury documented in the 1985 book DPT: A Shot in the Dark of children, who had milk allergy before or developed milk allergy after suffering a serious DPT vaccine reaction. Casein is a protein in milk and symptoms of milk allergy include frequent spitting up of milk after bottle or breast feeding; projectile vomiting of milk; frequent diarrhea; constipation; gas and abdominal pain; persistent crying after feedings (colic); eczema or recurrent skin rashes.

Children with casein allergy are often also allergic to foods containing gluten, which is a protein in wheat and other kinds of grains. The genes for both casein and gluten intolerance are inherited and symptoms can be mild or severe. Severe gluten intolerance is diagnosed as celiac disease, which can cause loss of weight and failure to thrive; gas and stomach pain; diarrhea/constipation; anemia; mouth ulcers; extreme fatigue (especially after eating gluten containing foods); and behavior disorders. If left undiagnosed without dietary elimination of foods containing gluten, celiac disease can lead to malnourishment and retarded growth in children; irritability; depression; seizures; permanent brain and immune system disorders or even death.